AAPL351.98-4.30 (-1.21%) ▼|ABBV294.62-0.41 (-0.14%) ▼|ABT107.88-0.64 (-0.59%) ▼|ACN247.50-2.99 (-1.19%) ▼|ADBE246.26+3.18 (+1.31%) ▲|AMAT351.30-19.20 (-5.18%) ▼|AMD502.08-31.99 (-5.99%) ▼|AMGN463.29-2.38 (-0.51%) ▼|AMT190.70-0.94 (-0.49%) ▼|AMZN257.61-9.06 (-3.40%) ▼|AVGO331.85-15.16 (-4.37%) ▼|AXP318.16-2.44 (-0.76%) ▼|BA165.02-6.49 (-3.78%) ▼|BAC49.95-1.08 (-2.11%) ▼|BKNG157.26-2.32 (-1.45%) ▼|BLK1,197.25-25.66 (-2.10%) ▼|BMY63.04-0.39 (-0.61%) ▼|BNY151.20-2.22 (-1.44%) ▼|BRK-B592.33-0.61 (-0.10%) ▼|C120.93-3.08 (-2.48%) ▼|CAT569.85-30.35 (-5.06%) ▼|CL101.48+1.81 (+1.82%) ▲|CMCSA25.52+0.36 (+1.43%) ▲|COF192.33-1.96 (-1.01%) ▼|COP140.01-1.35 (-0.95%) ▼|COST1,111.43+5.22 (+0.47%) ▲|CRM214.96-2.88 (-1.32%) ▼|CSCO94.10-1.54 (-1.61%) ▼|CVS88.46-0.90 (-1.00%) ▼|CVX216.66-3.23 (-1.47%) ▼|DE656.07-17.47 (-2.59%) ▼|DHR231.25-1.77 (-0.76%) ▼|DIS118.59-0.39 (-0.32%) ▼|DUK130.39+1.23 (+0.95%) ▲|EMR161.09-5.29 (-3.18%) ▼|FDX326.84+2.70 (+0.83%) ▲|GD359.24-4.22 (-1.16%) ▼|GE324.59-7.22 (-2.18%) ▼|GEV764.44-38.69 (-4.82%) ▼|GILD167.57-0.51 (-0.30%) ▼|GM83.38-2.62 (-3.05%) ▼|GOOG281.79-10.73 (-3.67%) ▼|GOOGL284.33-11.44 (-3.87%) ▼|GS889.40-27.16 (-2.96%) ▼|HD346.67-2.02 (-0.58%) ▼|HON217.97-4.49 (-2.02%) ▼|IBM241.93-5.20 (-2.10%) ▼|INTC55.57-4.09 (-6.86%) ▼|INTU346.40+4.70 (+1.38%) ▲|ISRG438.12-5.47 (-1.23%) ▼|JNJ283.53-2.22 (-0.78%) ▼|JPM337.49-8.70 (-2.51%) ▼|KO99.34+0.09 (+0.09%) ▲|LIN523.24-2.82 (-0.54%) ▼|LLY1,438.46-5.04 (-0.35%) ▼|LMT583.33-12.71 (-2.13%) ▼|LOW224.82-2.92 (-1.28%) ▼|LRCX212.04-13.88 (-6.14%) ▼|MA662.44+1.25 (+0.19%) ▲|MCD275.63+3.66 (+1.35%) ▲|MDLZ67.64+0.10 (+0.15%) ▲|MDT103.44+0.58 (+0.56%) ▲|META626.60-15.09 (-2.35%) ▼|MMM182.07-1.60 (-0.87%) ▼|MO78.65+0.01 (+0.01%) ▲|MRK146.04-1.72 (-1.16%) ▼|MS184.39-6.27 (-3.29%) ▼|MSFT517.87-6.01 (-1.15%) ▼|MU719.85-58.46 (-7.51%) ▼|NEE85.26+0.14 (+0.17%) ▲|NFLX60.77-1.38 (-2.22%) ▼|NKE38.20+0.21 (+0.55%) ▲|NOW99.65-2.60 (-2.54%) ▼|NVDA155.62-7.23 (-4.44%) ▼|ORCL118.53-6.82 (-5.44%) ▼|PEP146.60+1.16 (+0.79%) ▲|PFE28.91+0.02 (+0.07%) ▲|PG172.77+2.97 (+1.75%) ▲|PLTR159.70-8.30 (-4.94%) ▼|PM196.36-2.60 (-1.31%) ▼|QCOM169.92-2.56 (-1.48%) ▼|RTX194.66-3.92 (-1.97%) ▼|SBUX108.25+1.81 (+1.70%) ▲|SCHW92.73-0.25 (-0.27%) ▼|SO94.68+1.85 (+1.99%) ▲|SPG232.29-0.68 (-0.29%) ▼|T22.37+0.19 (+0.83%) ▲|TMO693.18-7.05 (-1.01%) ▼|TMUS169.91-0.05 (-0.03%) ▼|TSLA377.76-12.47 (-3.19%) ▼|TXN294.55-9.05 (-2.98%) ▼|UBER69.78+0.09 (+0.13%) ▲|UNH409.99+2.53 (+0.62%) ▲|UNP305.52+3.08 (+1.02%) ▲|UPS111.54+0.78 (+0.70%) ▲|USB60.26-0.74 (-1.21%) ▼|V426.03+0.27 (+0.06%) ▲|VZ46.38+0.02 (+0.03%) ▲|WFC84.52-1.53 (-1.78%) ▼|WMT128.26+0.17 (+0.13%) ▲|XOM166.90-2.62 (-1.55%) ▼|AAPL351.98-4.30 (-1.21%) ▼|ABBV294.62-0.41 (-0.14%) ▼|ABT107.88-0.64 (-0.59%) ▼|ACN247.50-2.99 (-1.19%) ▼|ADBE246.26+3.18 (+1.31%) ▲|AMAT351.30-19.20 (-5.18%) ▼|AMD502.08-31.99 (-5.99%) ▼|AMGN463.29-2.38 (-0.51%) ▼|AMT190.70-0.94 (-0.49%) ▼|AMZN257.61-9.06 (-3.40%) ▼|AVGO331.85-15.16 (-4.37%) ▼|AXP318.16-2.44 (-0.76%) ▼|BA165.02-6.49 (-3.78%) ▼|BAC49.95-1.08 (-2.11%) ▼|BKNG157.26-2.32 (-1.45%) ▼|BLK1,197.25-25.66 (-2.10%) ▼|BMY63.04-0.39 (-0.61%) ▼|BNY151.20-2.22 (-1.44%) ▼|BRK-B592.33-0.61 (-0.10%) ▼|C120.93-3.08 (-2.48%) ▼|CAT569.85-30.35 (-5.06%) ▼|CL101.48+1.81 (+1.82%) ▲|CMCSA25.52+0.36 (+1.43%) ▲|COF192.33-1.96 (-1.01%) ▼|COP140.01-1.35 (-0.95%) ▼|COST1,111.43+5.22 (+0.47%) ▲|CRM214.96-2.88 (-1.32%) ▼|CSCO94.10-1.54 (-1.61%) ▼|CVS88.46-0.90 (-1.00%) ▼|CVX216.66-3.23 (-1.47%) ▼|DE656.07-17.47 (-2.59%) ▼|DHR231.25-1.77 (-0.76%) ▼|DIS118.59-0.39 (-0.32%) ▼|DUK130.39+1.23 (+0.95%) ▲|EMR161.09-5.29 (-3.18%) ▼|FDX326.84+2.70 (+0.83%) ▲|GD359.24-4.22 (-1.16%) ▼|GE324.59-7.22 (-2.18%) ▼|GEV764.44-38.69 (-4.82%) ▼|GILD167.57-0.51 (-0.30%) ▼|GM83.38-2.62 (-3.05%) ▼|GOOG281.79-10.73 (-3.67%) ▼|GOOGL284.33-11.44 (-3.87%) ▼|GS889.40-27.16 (-2.96%) ▼|HD346.67-2.02 (-0.58%) ▼|HON217.97-4.49 (-2.02%) ▼|IBM241.93-5.20 (-2.10%) ▼|INTC55.57-4.09 (-6.86%) ▼|INTU346.40+4.70 (+1.38%) ▲|ISRG438.12-5.47 (-1.23%) ▼|JNJ283.53-2.22 (-0.78%) ▼|JPM337.49-8.70 (-2.51%) ▼|KO99.34+0.09 (+0.09%) ▲|LIN523.24-2.82 (-0.54%) ▼|LLY1,438.46-5.04 (-0.35%) ▼|LMT583.33-12.71 (-2.13%) ▼|LOW224.82-2.92 (-1.28%) ▼|LRCX212.04-13.88 (-6.14%) ▼|MA662.44+1.25 (+0.19%) ▲|MCD275.63+3.66 (+1.35%) ▲|MDLZ67.64+0.10 (+0.15%) ▲|MDT103.44+0.58 (+0.56%) ▲|META626.60-15.09 (-2.35%) ▼|MMM182.07-1.60 (-0.87%) ▼|MO78.65+0.01 (+0.01%) ▲|MRK146.04-1.72 (-1.16%) ▼|MS184.39-6.27 (-3.29%) ▼|MSFT517.87-6.01 (-1.15%) ▼|MU719.85-58.46 (-7.51%) ▼|NEE85.26+0.14 (+0.17%) ▲|NFLX60.77-1.38 (-2.22%) ▼|NKE38.20+0.21 (+0.55%) ▲|NOW99.65-2.60 (-2.54%) ▼|NVDA155.62-7.23 (-4.44%) ▼|ORCL118.53-6.82 (-5.44%) ▼|PEP146.60+1.16 (+0.79%) ▲|PFE28.91+0.02 (+0.07%) ▲|PG172.77+2.97 (+1.75%) ▲|PLTR159.70-8.30 (-4.94%) ▼|PM196.36-2.60 (-1.31%) ▼|QCOM169.92-2.56 (-1.48%) ▼|RTX194.66-3.92 (-1.97%) ▼|SBUX108.25+1.81 (+1.70%) ▲|SCHW92.73-0.25 (-0.27%) ▼|SO94.68+1.85 (+1.99%) ▲|SPG232.29-0.68 (-0.29%) ▼|T22.37+0.19 (+0.83%) ▲|TMO693.18-7.05 (-1.01%) ▼|TMUS169.91-0.05 (-0.03%) ▼|TSLA377.76-12.47 (-3.19%) ▼|TXN294.55-9.05 (-2.98%) ▼|UBER69.78+0.09 (+0.13%) ▲|UNH409.99+2.53 (+0.62%) ▲|UNP305.52+3.08 (+1.02%) ▲|UPS111.54+0.78 (+0.70%) ▲|USB60.26-0.74 (-1.21%) ▼|V426.03+0.27 (+0.06%) ▲|VZ46.38+0.02 (+0.03%) ▲|WFC84.52-1.53 (-1.78%) ▼|WMT128.26+0.17 (+0.13%) ▲|XOM166.90-2.62 (-1.55%) ▼|
13 C
New York
Monday, November 16, 2026

Tag: development

NANO Nuclear and the Namibian Government Sign Memorandum of Understanding to Develop Namibian Domestic Nuclear Fuel Supply Chain Infrastructure

New York, N.Y., June 20, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced the signing of a Memorandum of Understanding (MoU) with the Namibia Industrial Development Agency (NIDA) to explore collaborative opportunities focused on developing the domestic nuclear fuel supply chain infrastructure within the Republic of Namibia.

University of the People Pledges to Enroll 35,000 Refugees by 2030

Urges Global Universities to Take Action in Support of World Refugee Day PASADENA, Calif., June 20, 2025 /PRNewswire/ -- As the global refugee crisis intensifies,...

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

SAN DIEGO, June 20, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life...

SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors

– If approved, nirogacestat will be the first and only therapy with marketing authorization in the EU for the treatment of desmoid tumors –

Time Temperature Indicator Market to Reach $1.57 Billion by 2035, Growing at a CAGR of 6.2% from 2025–Exclusive Report by Meticulous Research®

Market Growth Driven by Cold Chain Expansion, IoT Integration, Regulatory Compliance Requirements, and Focus on Food Safety REDDING, Calif., June 20, 2025 /PRNewswire/ -- According to...

Time Temperature Indicator Market to Reach $1.57 Billion by 2035, Growing at a CAGR of 6.2% from 2025–Exclusive Report by Meticulous Research®

Market Growth Driven by Cold Chain Expansion, IoT Integration, Regulatory Compliance Requirements, and Focus on Food Safety REDDING, Calif., June 20, 2025 /PRNewswire/ -- According to...

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA

Notes accelerating 2026 revenue bookings forecast Secures incremental non-dilutive financing WASHINGTON, June 20, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving...

Biomarkers and New Therapeutic Strategies to Better Treat Brain Cancer

INRS Professor receives $1.2M to advance glioblastoma research  LAVAL, QC, June 20, 2025 /CNW/ - Professor Maya Saleh, a world-renowned expert in immuno-oncology at the Institut national...

Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:

SEOUL, South Korea and NEW YORK, June 20, 2025 /CNW/ -- Parataxis Holdings LLC ("Parataxis Holdings"), an affiliate of Parataxis Capital Management LLC ("Parataxis Capital"...

Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:

SEOUL, South Korea and NEW YORK, June 20, 2025 /PRNewswire/ -- Parataxis Holdings LLC ("Parataxis Holdings"), an affiliate of Parataxis Capital Management LLC ("Parataxis Capital"...

Yiren Digital’s Hexiang Insurance Brokers Launched Innovative Insurance Products for Low-Altitude Economy

BEIJING, June 20, 2025 /PRNewswire/ -- Hexiang Insurance Brokers, the insurance brokerage arm of Yiren Digital, has successfully launched specialized insurance products targeting China's...

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.3,4 A final decision on the approval in the European Union is expected in the coming months.

The Week in Canadian Press Releases: 10 Stories You Need to See

A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, June 20, 2025 /CNW/ - With thousands of press releases published...

Cyberway: ‘AI Middle Platform + AI Agent’ Dual Driver, [CYBER AI] Wisdom Empowerment to Build Enterprise-level AI Brain

GUANGZHOU, China, June 20, 2025 /PRNewswire/ -- With the maturation of AI technology, its application in the FMCG sector holds enormous potential. Building private AI...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment